Real-time enrollment status for this relapsed adult aml clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT06613217 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Adult AML |
| Phase | Clinical Trial |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pacylex Pharmaceuticals |
| Last Updated on CT.gov | March 10, 2025 (Mar 10, 2025) |
As of July 13, 2026: Clinical trial NCT06613217 is currently recruiting participants. This clinical trial study for relapsed adult aml is actively seeking new participants at 1 location across the United States. The study is sponsored by Pacylex Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06613217 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06613217 was last updated Mar 10, 2025 (March 10, 2025). HelloStudys verifies this status automatically.